<DOC>
	<DOC>NCT01303562</DOC>
	<brief_summary>The goal of this placebo-controlled, 3-way crossover study is to determine the acute (24-h) bioavailability and pharmacokinetics of the major phytochemicals found whole barley and oats, as well as their effects on selected measures of antioxidation, inflammation, insulin sensitivity/glucose regulation, and vascular remodeling following challenge by an oral glucose tolerance test (OGTT).</brief_summary>
	<brief_title>Clinical Assessment of Barley and Oat Phytochemicals</brief_title>
	<detailed_description />
	<criteria>Men and postmenopausal women BMI 2735.9 kg/m2 Cigarette smoking and/or nicotine replacement use Individuals taking estrogen Use of cholesterollowering medications Use of blood pressurelowering medications Regular use of any stomach acidlowering medications or laxatives (including fiber supplements) Cardiovascular (heart) disease Gastrointestinal disease Kidney disease Endocrine disease: including diabetes, untreated thyroid disease Rheumatoid arthritis Active treatment for any type of cancer, except basal cell carcinoma, within 1 year prior to study admission Systolic blood pressure &gt; 150 mmHg and/or diastolic blood pressure &gt; 95 mmHg Regular use of oral steroids Regular daily intake of â‰¥ 2 alcoholic drinks Infrequent or excessive number of regular bowel movements Illicit drug use Vegetarians No fish oil supplements (including cod liver oil) for one month prior to study admission No dietary supplements, including those containing any vitamins, minerals, herbs, plant concentrates (including garlic, gingko, St. John's wort) or homeopathic remedies, for one month prior to study admission</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>oat</keyword>
	<keyword>barley</keyword>
	<keyword>whole grain</keyword>
	<keyword>bioavailability</keyword>
	<keyword>phytochemical</keyword>
</DOC>